By Izzy Wood (Drug Target Review)2023-05-08T12:00:13
US researchers developed a next-generation computational tool called NetBID2 that can uncover difficult-to-identify proteins that drive biological processes contributing to cancer.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2024-01-26T13:22:42
Sponsored by bit.bio
2023-03-28T11:38:32
Sponsored by Bio-Techne
2023-07-04T10:05:58
Sponsored by Revvity
2024-02-01T12:06:43
Sponsored by Leica Microsystems
2024-01-24T12:52:38
Sponsored by BellBrook Labs
2023-12-11T10:49:07
Sponsored by Leica Microsystems
Site powered by Webvision Cloud